Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 520
- 试验地点
- 1
- 主要终点
- cure rate
研究概览
简要总结
The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.
详细描述
A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 15 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •School children
排除标准
- •Taking praziquantel
研究组 & 干预措施
Praziguantel
tablet single dose
干预措施: praziquantel (Drug)
结局指标
主要结局
cure rate
时间窗: one year
The reduction of the prevalence and intensity of S.haematobium infection following a single dose of praziquantel40mg/kg
次要结局
- reduction in the intensity of infection by(one year)
研究者
Ishag Adam
Professor
University of Khartoum
